Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) | Analysis of Investments

Mark to market Regeneron available-for-sale securities. Adjustment to net income and profitability ratios such as net profit margin ratio, return on equity ratio (ROE), and return on assets ratio (ROA).

市场调整日终估值：再生元公司可供出售证券。对净利润及盈利比率如净利润边际比率、净资产收益率（ROE）和总资产收益率（ROA）的调整。